CashNews.co The drug and biotech industry has done well this year, driven by increased mergers and acquisitions (M&A), the launch of promising new medicines and pipeline successes. Obesity drugs of Novo Nordisk and Eli Lilly LLY have witnessed tremendous success, which has played a key role in the industry’s outperformance. Large drugmakers have several robust […]
